Nintedanib With Gemcitabine And Cisplatin For Neoadjuvant Treatment Of Bladder Cancer

Nintedanib With Gemcitabine and Cisplatin for Neoadjuvant Treatment of Bladder Cancer

NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invas...

BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle...

NEO-BLADE trial: nintedanib and chemotherapy in bladder cancer

Phase II study of neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with MIBC

Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Bladder Cancer

Grand Rounds in Urology

Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patients

European Association of Urology

Enzalutamide, Gemcitabine, and Cisplatin for Metastatic Bladder Cancer

Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer

Grand Rounds in Urology

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of MIBC patients

Dr. Tyson on Rationale for Neoadjuvant Chemotherapy in Bladder Cancer

A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma

Nivolumab, Gemcitabine & Cisplatin for Patients w Muscle-Invasive Bladder Cancer Undergo Cystectomy

Dose-Dense MVAC vs Gemcitabine/Cisplatin for Preop Treatment of Muscle-Invasive Bladder Cancer

Borealis-1™: Phase 2 trial of gemcitabine/cisplatin plus apatorsen in advanced bladder cancer

EMJ

Contemporary Neoadjuvant Chemotherapy for Bladder Cancer

Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC

Neoadjuvant Chemotherapy Plus Nivolumab and BMS-986205 for Muscle Invasive Bladder Cancer

Treating Bladder Cancer 4 - Chemotherapy and Bladder Cancer

Bladder Cancer Advocacy Network

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible patients with m...